In recurrent or metastatic head and neck squamous cell carcinoma, higher CD73 expression on neoplastic cells correlates with early progression on immune−checkpoint blockade, consistent with an adenosine−conditioned microenvironment that diminishes effector function (64–66). Here, NT5E is linked to head and neck squamous cell carcinoma.